Skip to main content

Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire

Abstract

Aims

The aim of this study was to translate and validate chronic liver disease questionnaire (CLDQ) into Bengali using a standard protocol and use it to assess the impact of socioeconomic factors, etiology, disease severity and complications on the quality of life of patients.

Methods

Formal translation of CLDQ to Bengali was done. Cronbach’s alpha and test-retest was performed for reliability analysis. Patients with clinically stable chronic liver disease (CLD) without significant associated co-morbid states were administered Bengali CLDQ in the Liver Clinic. The clinical, biochemical and disease parameters were recorded for analysis.

Results

Bengali CLDQ was administered to 100 patients with CLD. Cronbach’s alpha of overall scores was 0.90 and test-retest correlation coefficient of average CLDQ was 0.86 (P < 0.001). Patients with history of decompensation (96.51 vs. 109.61; P = 0.039) and Child’s C status (92.24 vs. 105.71; P = 0.028) had significantly lower CLDQ scores. CLDQ scores showed a moderate inverse correlation with Child’s status (r = −0.35) and a poor correlation with MELD score (r = −0.09).

Conclusion

Bengali translation of CLDQ was found to be reliable. History of decompensation, Child’s C status was associated with worse CLDQ scores. Child’s status may have some role in predicting quality of life of patients with CLD. MELD score had poor predictability of quality of life.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. 1.

    WHO. Constitution of the World Health Organization. In: World Health Organization. Handbook of basic documents. 5th ed. Geneva: Palais des Nations; 1952. p. 3–20

  2. 2.

    Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet. 1999;354:816–9.

    CAS  PubMed  Google Scholar 

  3. 3.

    El-Dika S, Guyatt GH, Armstrong D, et al. The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol. 2005;5:23.

    Article  PubMed  Google Scholar 

  4. 4.

    Glise H, Wilklund I. Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol. 2002;17(Suppl):S72–S84.

    Article  PubMed  Google Scholar 

  5. 5.

    Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol. 2004;99:1726–32.

    Article  PubMed  Google Scholar 

  6. 6.

    Gralnek IM, Hays RD, Kilbourne A, et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0. Am J Gastroenterol. 2000;95:3552–65.

    CAS  PubMed  Google Scholar 

  7. 7.

    Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut. 2000;47:444–54.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol. 2001;96:579–83.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–78.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Chong CA, Gulamhussein A, Heathcote EJ, et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol. 2003;98:630–38.

    Article  PubMed  Google Scholar 

  12. 12.

    Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life of patients with hepatocellular carcinoma. Dig Liver Dis. 2003;35:46–54.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–205.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–6.

    Article  PubMed  Google Scholar 

  15. 15.

    Cordoba J, Flavia M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol. 2003;39:231–8.

    Article  PubMed  Google Scholar 

  16. 16.

    Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol. 2004;10:1954–7.

    PubMed  Google Scholar 

  17. 17.

    Ferrer M, Córdoba J, Garin O, et al. Validity of the Spanish version of the chronic liver disease questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006;12:95–104.

    Article  PubMed  Google Scholar 

  18. 18.

    Zuberi BF, Memon AR, Afsar S, Qadeer R, Kumar R. Correlation of quality of life in patients of cirrhosis of liver with etiology and disease severity using disease-specific quality of life questionnaire. J Ayub Med Coll Abottabad. 2007;19:7–11.

    Google Scholar 

  19. 19.

    Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the chronic liver disease questionnaire. Eur J Gastroenterol Hepatol. 2004;16:599–606.

    Article  PubMed  Google Scholar 

  20. 20.

    Tiwari R, Aggarwal A, Devi P. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses amongst drug users in Amritsar. Indian J Med Microbiol. 2006;24:151–2.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Kawabata K, Xu K, Carrin G. Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ. 2002;80:612.

    PubMed  Google Scholar 

  22. 22.

    Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.

    Article  Google Scholar 

  23. 23.

    Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758–69.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Bland JM, Altman DG. Cronbach’s alpha. BMJ 1997;314:572.

    CAS  PubMed  Google Scholar 

  25. 25.

    Bergner M, Bobbit RA, Pollard WE, et al. The sickness impact profile: validation of a health status measure. Med Care. 1976;14:57–67.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    McSweeny AJ, Creer TL. Health-related quality-of-life assessment in medical care. Dis Mon. 1995;41:1–7l.

    CAS  PubMed  Google Scholar 

  27. 27.

    Bush JW. General health policy model/quality of well-being (QWB) scale. In: Wenger NK, Mattson ME, Furberg CD, et al. eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: LeJacq; 1984. p. 189–99.

    Google Scholar 

  28. 28.

    Andresen EM, Rothenberg BM, Kaplan RM. Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Med Care. 1998;36:1349–60.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Stewart AL, Hays RD, Ware JE Jr. The MOS short form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724–35.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Tarlov AR, Ware JE Jr, Greenfield S, et al. The medical outcomes study: an application of methods for monitoring the effects of medical care. JAMA. 1989;262:925–30.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473–83.

    Article  PubMed  Google Scholar 

  32. 32.

    Kanwal F, Gralnek IM, Hays RD, et al. Spiegel BM Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793–9.

    Article  PubMed  Google Scholar 

  33. 33.

    Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology. 2007;45:806–16.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Marcellin P, Lau GK, Zeuzem S, et al. Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int. 2008;28:477–85.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgement

The authors would like to acknowledge Younossi ZM et al. for giving permission to adapt CLDQ to Bengali. This study has not been funded.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Deep Dutta.

Additional information

Pallavi Basu is presently working with McKinsey & Co., Gurgaon, India.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ray, I., Dutta, D., Basu, P. et al. Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire. Indian J Gastroenterol 29, 187–195 (2010). https://doi.org/10.1007/s12664-010-0036-x

Download citation

Keywords

  • Alcoholic liver disease
  • Chronic hepatitis B
  • Chronic hepatitis C
  • Quality of life
  • Questionnaire